Inventor · disambiguated record
Marlene Thomas
Also filed as: THOMAS MARLENE
17 granted patents·11 pending applications·157 citations·filing 2011–2025
95Inventor score
Top patents by PatentIndex Score
28 records- 0195US9499625B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Nov 22, 2016·12 cites·33 claims
- 0294US9879085B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2017·Granted Jan 30, 2018·10 cites·20 claims
- 0394US9663580B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted May 30, 2017·11 cites·20 claims
- 0494US9499626B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Nov 22, 2016·12 cites·31 claims
- 0593US9624302B2Nucleic acids encoding antibodies against human CSF-1RHOFFMANN LA ROCHE·Filed 2015·Granted Apr 18, 2017·11 cites·11 claims
- 0693US9617342B2Nucleic acids encoding antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Apr 11, 2017·11 cites·9 claims
- 0793US9499624B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2014·Granted Nov 22, 2016·12 cites·15 claims
- 0892US9221910B2Antibodies against human CSF-1RFERTIG GEORG·Filed 2011·Granted Dec 29, 2015·20 cites·12 claims
- 0991US10077314B1Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted Sep 18, 2018·5 cites·20 claims
- 1091US10072087B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2017·Granted Sep 11, 2018·5 cites·20 claims
- 1191US9169323B2Antibodies against human CSF-1RFERTIG GEORG·Filed 2011·Granted Oct 27, 2015·13 cites·15 claims
- 1290US9988458B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Jun 5, 2018·6 cites·14 claims
- 1389US10030073B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Jul 24, 2018·5 cites·23 claims
- 1488US10287358B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted May 14, 2019·3 cites·20 claims
- 1588US9180185B2Combination therapy of anti-HER3 antibodiesHOFFMANN LA ROCHE·Filed 2014·Granted Nov 10, 2015·13 cites·15 claims
- 1684US10336830B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted Jul 2, 2019·3 cites·15 claims
- 1783US10023643B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2012·Granted Jul 17, 2018·5 cites·7 claims
- 1879US2022282337A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1978US2025340948A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 2078US2022170115A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2176US2022090212A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2271US2019300614A1Antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 2370US2020199690A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2466US2018274038A1Identification of patients in need of pd-l-1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 2564US2015080556A1Antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2661US2016333414A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 2753US2017275368A1Antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 2841US2016159912A1Combination therapy of anti-her3 antibodiesHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marlene Thomas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →